Showing 5341-5350 of 5909 results for "".
- CovalentCareers Releases 2019 Optometrist Reporthttps://modernod.com/news/covalentcareers-releases-2019-optometrist-report/2477100/Career development company CovalentCareers has released its 2019 Optometrist Report, which is now available for free for eyecare professionals. Based on data collected from 1,181 optometrists, optometry studen
- Katena Announces the Acquisition of Micro Medical Instrumentshttps://modernod.com/news/katena-announces-the-acquisition-of-micro-medical-instruments/2477093/Katena Products announced the purchase of Micro Medical Instruments (MMI), a medical contract manufacturing service. Terms of the deal were not disclosed. “The acquisition of MMI, Inc. will strengthen Katena’s manufacturing capability,” Mark Fletcher, CEO of Katena Products, said i
- Iveric bio Initiating Second Pivotal Clinical Trial of Zimura in GA Secondary to Dry AMDhttps://modernod.com/news/iveric-bio-initiating-second-pivotal-clinical-trial-of-zimura-in-ga-with-1q-2020-targeted-for-first-patient-enrolled/2477090/Iveric bio provided further clinical details and its development strategy for Zimura (avacincaptad pegol), a novel complement C5 inhibitor, for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). Based on the study design and the robustness of the rec
- Armenian EyeCare Project Surpasses Milestone of 10,000 Patients Screened Using Artificial Intelligence Eye Screening Technologyhttps://modernod.com/news/armenian-eyecare-project-surpasses-milestone-of-10000-patients-screened-using-artificial-intelligence-eye-screening-technology/2477088/On this World Diabetes Day, the Armenian EyeCare Project (AECP), a nonprofit organization dedicated to eliminating preventable blindness in Armenia, announced that it has surpassed the milestone of screening 10,000 patients for diabetic retinopathy (DR) throughout Armenia utilizing the state-of-a
- Bausch + Lomb and TerraCycle Announce Donation of New Custom Training Modules to Guide Dog Foundationhttps://modernod.com/news/bausch-lomb-and-terracycle-announce-donation-of-new-custom-training-modules-to-guide-dog-foundation/2477087/Bausch + Lomb in collaboration with TerraCycle, a leader in the collection and repurposing of hard-to-recycle post-consumer waste, announced the donation of custom training modules to the Guide Dog Foundation, a national not-for-profit that trains guide dogs for people who are blind or visually i
- Envision Announces Dates, Calls for Submissions for 2020 Conferenceshttps://modernod.com/news/envision-announces-dates-calls-for-submissions-for-2020-conferences/2477082/Envision announced that it is now accepting submissions for clinical education and research presentations for its two annual conferences in 2020: Envision Conference West, April 3-4, UT Health San Antonio Department of Occupational Therapy in San Antonio, Texas; and Envision Conference East, Augu
- Novaliq and Jiangsu Hengrui Medicine Announce a Collaboration for Investigational NOV03 and CyclASol in Chinahttps://modernod.com/news/novaliq-and-jiangsu-hengrui-medicine-announce-a-strategic-collaboration-in-ophthalmology-for-the-eyesol-based-investigational-products-nov03-and-cyclasol-in-china/2477080/Novaliq and Jiangsu Hengrui Medicine, a biopharmaceutical company based in China, announced the closing of an exclusive license agreement to develop, manufacture and commercialize water-free drugs NOV03 and CyclASol for the treatment of dry eye disease in the People’s Republic of China (including
- Ocular Therapeutix Announces Strategic Update and Operational Restructuringhttps://modernod.com/news/ocular-therapeutix-announces-strategic-update-and-operational-restructuring/2477081/Ocular Therapeutix announced an operational restructuring plan that the company says is expected to result in an estimated $11 million in annualized savings through personnel reductions and approximately $14 million in one-time program deferrals. The company estimates that it will record costs as
- Optina Diagnostics and Wagner Macula Retina Center to Conduct a Study to Identify the Causes of Memory Loss Through Eye Diagnosticshttps://modernod.com/news/optina-diagnostics-and-wagner-macula-retina-center-will-collaborate-to-conduct-a-clinical-study-to-identify-the-causes-of-memory-loss-through-eye-diagnostics/2477076/Optina Diagnostics and Wagner Macula Retina Center are entering into a collaboration agreement to conduct a clinical study for the advancement of Optina’s Retinal Deep Phenotyping platform. This collaboration will lay the groundwork for Optina’s future pivotal clinical trial. &
- Ocuphire Pharma Announces Results from Two Phase 2 Clinical Studies of Nyxol Eye Dropshttps://modernod.com/news/ocuphire-pharma-announces-results-from-two-phase-2-clinical-studies-of-nyxol-eye-drops/2477075/Ocuphire Pharma announced statistically significant and clinically meaningful results from its recently completed two phase 2b studies of its lead drug candidate, Nyxol Eye Drops. Topline results of the primary and secondary endpoints of the MIRA-1 and ORION-1 studies provided confirmatory